Parexel Extends Asia/Pacific Capability

Article

Applied Clinical Trials

Parexel has announced the expansion of its capabilities, to optimize drug development and commercialization, in Asia/Pacific through a new Hong Kong presence established by its healthcare consulting Health Advances subsidiary.

To learn more, click here. 

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.